1/131
Looks like no tags are added yet.
DSM 5 Diagnosis: GAD
at least 6 months of symptoms, difficulty controlling the worry
presence of at least 3 symptoms: feeling keyed up or on edge, becoming easily fatigued, mind going blank, irritability, muscle tension, sleep disturbance
Clinical Presentation of GAD
irritability
restlessness
excessive worry
racing thoughts
sweating/blushing
tachycardia, arrhythmias
chest pain, muscle tightness, N/V/D
decreased social and occupational function
GAD-7 5-9
mild
GAD-7 10-14
moderate
GAD-7 > 15
severe
DSM5 Panic Disorder
recurrent unexpected panic attacks with at least 1 of the attacks being followed by a month or longer of at least 1 of the following:
constant concern about having another one
being anxious about implications of attack
maladaptive change in behavior designed to avoid it
Panic Attacks
spontaneous, unexpected, transient period of intense fear (lasts 20-30 minutes)
at least 4 of the following symptoms:
palpitations, diaphoresis, trembling, SOB, choking feeling, chest pain, paresthesia, chills/hot flashes, fear of dying, derealization, dizziness/faintness, fear of going crazy
Panic Attack vs Disorder
attack= single event
disorder = several attacks + persistent fear ( > 1 mo)
Risk factors for social anxiety disorder
over-protection from parental control, early childhood anxiety disorders, life stressors, psychiatric comorbidities, adverse life experiences
DSM-5 SAD
significant anxiety or fear about at least one social situation where the individual is exposed to possible scrutiny by others
fears display anxiety symptoms or act in a way that will be negatively assessed
anxiety, fear, avoidance is persistent with duration of 6 months or longer
Clinical Presentation of SAD
fears: embarrassment, humiliation, scrutinized by others
feared situations: public speaking, eating or drinking in front of others, interacting with authority figures
physical: blushing, butterflies, diarrhea, sweating, tachy
Clinical Presentation of PTSD
intrusion: feeling that traumatic event is recurring, recurrent, disturbing dreams of event
avoidance: avoidance of thoughts feelings or conversations and reminders
reactivity: decreased concentration, easily startled, reckless behavior
mood/cognition: inability to recall important aspects of trauma, negative expectations, distorted cognitions
Short Term Goals of anxiety disorders
reduce symptoms frequency and severity
improve function
Long Term Goals of anxiety disorders
symptom remission
no functional impairment
improved quality of life
What is first line for anxiety disorders?
SSRI/SNRIs
Counseling Points for SSRIs and SNRIs
initial symptom improvement takes at least 2-4 weeks, may take up to 8 weeks
adequate trial: 12 weeks
titrate to optimal dose
avoid abrupt discontinuation
What anxiety disorders does pregabalin have efficacy for?
generalized and social anxiety disorder
Onset of effect of pregabalin
< 1 week
works a lot faster, and can be considered 1st line option for GAD
Adverse effects of Pregabalin
edema
sedation
vision changes (dose-dependent)
weight gain
Starting Dose of Pregabalin
150 mg daily in 3 divided doses (50 mg TID)
take after a meal to increase bioavailability
target dose: 150-600 mg/day; increase by 150 mg/day each week
Precautions and warnings for Pregabalin
risk of respiratory depression with opioids and other medications
At what CrCl should you decrease dose of pregabalin?
< 60 mL/min
Drug interactions of pregabalin
opioids, alcohol, CNS depressants
What is buspirone FDA approved for?
generalized anxiety disorder
Place in therapy for Buspirone in GAD
effective 2nd line monotherapy or augmentation in GAD
Initial dosing for buspirone
5 mg BID/TID
titrate 5 mg every 2-3 days
typical dose: 15 mg BID
When is busiprone NOT recommended for use?
those with hepatic or renal impairment
Adverse effects of buspirone
generally well tolerated
nausea/dizziness/headache
Drug Interactions of Buspirone
CYP3A4 inhibitors and inducers
Warnings/Precautions of Buspirone
may cause akathisia
Counseling Points of Buspirone
delayed onset of action, similar to SSRIs/SNRIs
not a PRN medication - needs to be taken consistently for best effect
What is hydroxyzine approved for?
generalized anxiety disorder
What is hydroxyzine usually used for?
often "as needed" due to onset of action (effects seen within 30 minutes)
considered 2nd line therapy in GAD, could also be useful for insomnia with anxiety
Dosing for Hydroxyzine
25 mg BID scheduled OR prn
Dosing Adjustments for Hydroxyzine
ELDERY, due to adverse effects must use lower doses
hepatic impairment: expand to every 24 hours
Warning/Precautions for hydroxyzine
BPH
dementia
constipation
narrow angle glaucoma
CNS depression
elderly
Adverse effects of Hydroxyzine
anticholinergic (constipation, blurred vision, dry mouth), sedation
Drug Interactions of Hydroxyzine
alcohol, BZDs, opioids, TCAs, benztropine, other antihistamines
What TCAs are used in anxiety disorders?
imipramine, clomipramine, amitriptyline
Place in therapy for TCAs in anxiety disorders
useful when SSRI/SNRIs are ineffective or unable to be tolerated by patients
Why are TCAs limited in use in anxiety disorders?
poor tolerability and risk of serious adverse reactions
Which MAOI is most commonly used in anxiety disorders?
phenelzine
Place in therapy for phenelzine
at least 3rd line agent
only in patients refractory to standard treatment and augmentation
literally last line
Can SGAs be used as monotherapy in anxiety disorders?
NEVER EVER EVER
What SGAs are most effective/studied in anxiety disorders?
olanzapine, risperidone and quetiapine
Place in therapy for SGAs in anxiety disorder
viewed as alternative and or adjunct therapy in TREATMENT RESISTANT anxiety disorders
Which SGA works the best in GAD and PTSD?
quetiapine
Which SGA works best in SAD
olanzapine
What two drugs can be used as add-on therapy for sleep disturbances (nightmares) in PTSD?
prazosin and clonidine
Prazosin
alpha 1 agonist, used for sleep disturbances in ptsd
dose at bedtime: 1-16 mg/day
Clonidine
alpha 2 agonist, used for sleep disturbances in ptsd
dose variable: 0.2-0.6 mg daily, divided doses
Side effects of prazosin
orthostatic hypotension, dizziness, palpitations, first dose syncope
Side effects of clonidine
hypotension, dry mouth, dizziness, syncope, rebound hypertension
Benzodiazepines
generally utilized as add-on or second line (typically not used as monotherapy)
can be useful in acute phase management of anxiety (2-3 weeks until full effect of antidepressants)
Are benzodiazepines useful in ptsd?
nope
Adverse Effects of Benzodiazepines
sedation, psychomotor impairment, impaired cognition, vision changes, hypotension, dry mouth, amnesia, coma, respiratory depression
Patients who take BZDs long term...
higher risk for memory and concentration problems, daytime fatigue, falls and fractures, increased risk of having a moto vehicle accident while driving
What are some additional concerns with benzodiazepines?
misuse, addiction and overdose
What two benzodiazepines are preferred in older adults?
lorazepam and oxazepam
Are all benzodiazepines dosed the same?
no! there is a chart that you can base doses off of lorazepam
Which benzodiazepines are short acting?
alprazolam
lorazepam
oxazepam
Which benzodiazepines are long acting?
clonazepam
chlordiazepoxide
diazepam
PK/PD result in elderly with BZDs
increases drug exposure
Common Symptoms of Benzodiazepine Withdrawal
anxiety, insomnia, restlessness, muscle tension, irritability
SEIZURES
Seizures in BZD withdrawal
usually occurs with short half life agents and occur within 3 days of abrupt discontinuation
can occur up to 1 week or later after abrupt discontinuation in longer half life agents
Who is at risk to experiences seizures with BZDs withdrawal?
higher doses
longer duration of use
combination of other agents that lower seizure threshold
Discontinuation Principle of BZD
10-25% reduction every 1-2 weeks UNTIL 50% of dose is reached
pause and stabilize at 50% of dose
then once stabilized, resume but utilize lower % reduction and space out taper
SSRI/SNRIs are useful with co-morbid
MDD
Pregabalin is useful with co-morbid
chronic pain
TCA may be useful with co-morbid
insomnia
DSM-5 Diagnosis for OUD and AUD
decline in functioning: failure to fulfill major role, important social, occupational or recreational activities are reduced or given up
loss of control: taking larger amounts or for a longer time period, persistent desire, trying to obtain, craving
continued use despite negative consequences
OUD (opioid use disorder) AND AUD (alcohol use disorder)
problematic pattern of substance use with clinically significant distress or impairment with at least 2 of the following within a 12 month period
Short Term goals of treatment for OUD
eliminate withdrawal and cravings
reduce immediate risk associated with opioid misuse
Long Term Goals of Treatment for OUD
increase social functioning
remission of opioid addiction
What medications can be used for OUD?
methadone
buprenorphine/naloxone (suboxone)
naltrexone
Onset of Action of Methadone
within hours
but a FULL opioid agonist (so could have more withdrawal)
What is the restriction of methadone?
controlled substance that has to be obtained from a clinic
must be prescribed, dispensed, and administered
Patient Considerations for Methadone
long half life (once daily)
consider for pregnant patients
good for those who need structured environment
no withdrawal required to start treatment
What is required to be offered for every opioid use medication?
naloxone
Safety Monitoring for Methadone
RR, HR, BP, QTc, urine drug screens
Counseling Points for methadone
avoid alcohol and BZD
if admitted, dose and adherence needs to be confirmed by OTP
Patient Considerations for Suboxone
can be dispensed at local pharmacy
long half life
multiple formulations available
standard induction requires mild-mod opioid withdrawal
Counseling Points for Suboxone
avoid acidic drinks and nicotine prior to dose
avoid alcohol and BZDs
CAN split tablet or film
HOLD tablet or film under tongue for several minutes until it dissolves
Microinduction Theory with Suboxone
gradual increase of buprenorphine dose will incrementally displace full agonist but not enough to precipitate withdrawal
once target dose achieved (16 mg/day), full agonist can be displaced and stopped
Patient Considerations for Naltrexone
non-opioid agonist option (for those wanting to avoid opioids in treatment)
long acting INJECTABLE
no abuse potential
approved for OUD and AUD
Warnings and Precautions for Naltrexone
acute hepatitis
severe hepatic impairment
depression and suicidal thoughts
DO NOT USE IN PREGNANT PATIENTS
caution in decompensated cirrhosis and those with renal impairment
Initiation of Naltrexone
MUST be off opioids for a minimum of 7-10 days
onset: 24 hours (IM)
Counseling Points for Naltrexone
opioid free for > 7-10 days
alert all providers that you are on this
avoid opioids for pain management
injection is every 28 days
ensure have emergency card
must be observed taking this medication for OUD
Does naltrexone reduce withdrawal symptoms?
no
Which MOUD has mortality benefits?
buprenorphine and methadone
Goals of Treatment for Maintenance of AUD
decrease number of days drinking, heavy drinking, and drinks per day
minimize physical, psychological, financial, and social harm
What are the three drugs that can be used for AUD?
acamprosate, disulfiram, naltrexone
Acamprosate
TID dosing
oral tablet
adverse events: diarrhea, insomnia, anxiety, depression, weakness
Contraindications for Acamprosate
CrCl < 30 mL/min
Warnings and Precautions for Acamprosate
suicidal ideation and depression, alcohol withdrawal (DOES NOT TREAT), renal impairment
Disulfiram
250 mg daily, oral tablet
Contraindications for Disulfiram
severe myocardial disease
use of alcohol products within 14 days after discontinuing
psychosis
recent or current use of metro
How long does disulfiram effect last after last dose?
1-2 weeks
When should you NOT initiate disulfiram?
at least 12-24 hours after ingesting alcohol
BAL of 0 required
Adverse effects of disulifram
disulifram reaction: warmness and flushing of skin, increased HR, palpitations, decreased BP